(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.13%) $0.928
(0.17%) $10.86
(-0.01%) $0.792
(-0.30%) $92.30
Live Chart Being Loaded With Signals
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe...
Stats | |
---|---|
Today's Volume | 3.62M |
Average Volume | 2.39M |
Market Cap | 178.90M |
EPS | £0 ( 2023-09-28 ) |
Next earnings date | ( £0 ) 2024-04-22 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -3.11 |
ATR14 | £0.166 (0.33%) |
Volume Correlation
Avacta Group PLC Correlation
10 Most Positive Correlations | |
---|---|
TEM.L | 0.92 |
JAGI.L | 0.92 |
XMMS.L | 0.893 |
FCSS.L | 0.889 |
HSXJ.L | 0.885 |
EMIM.L | 0.885 |
JMG.L | 0.883 |
FEMS.L | 0.88 |
AEMD.L | 0.876 |
LAND.L | 0.875 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Avacta Group PLC Correlation - Currency/Commodity
Avacta Group PLC Financials
Annual | 2022 |
Revenue: | £9.65M |
Gross Profit: | £4.23M (43.83 %) |
EPS: | £-0.150 |
Q2 | 2023 |
Revenue: | £11.89M |
Gross Profit: | £5.04M (42.35 %) |
EPS: | £-0.0428 |
Q4 | 2022 |
Revenue: | £4.14M |
Gross Profit: | £281 000 (6.79 %) |
EPS: | £-0.120 |
Q2 | 2022 |
Revenue: | £5.52M |
Gross Profit: | £3.95M (71.60 %) |
EPS: | £-0.0356 |
Financial Reports:
No articles found.
Avacta Group PLC
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators